Marksans Pharma

Marksans Pharma Ltd Key Ratios

NSEBSE

₹249.95

(-1.34%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Marksans Pharma Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Growth matrix (%)
Revenue growth	21.33	24.27	18.97	-14.12
Op profit growth	76.64	122.26	93.32	-67.16
EBIT growth	86.92	176.46	176.91	-81.47
Net profit growth	103.84	255.25	272.68	-88.74
Profitability ratios (%)
OPM	24.67	16.95	9.47	5.83
EBIT margin	22.53	14.62	6.57	2.82
Net profit margin	17.33	10.31	3.6	1.15
RoCE	37.8	25.56	10.32	3.9
RoNW	7.83	5.28	1.82	0.49
RoA	7.26	4.5	1.41	0.39
Per share ratios (₹)
EPS	5.83	2.95	0.87	0
Dividend per share	0.25	0.1	0.05	0.05
Cash EPS	4.94	2.2	0.14	-0.51
Book value per share	21.65	15.53	11.5	10.58
Valuation ratios
P/E	8.56	4.71	36.37	0
P/CEPS	10.1	6.29	212.31	-90.8
P/B	2.3	0.89	2.75	4.45
EV/EBIDTA	5.38	2.62	15.81	38.91
Payout (%)
Dividend payout	0	0	7.48	192.97
Tax payout	-21.05	-23.17	-28.1	-23.91
Liquidity ratios
Debtor days	68.33	67.62	84.88	110.58
Inventory days	85.68	74	81.62	85.13
Creditor days	-49.11	-36.45	-52.92	-70.92
Leverage ratios
Interest coverage	-38.83	-18.96	-5.87	-3.19
Net debt / equity	-0.2	-0.1	0.16	0.19
Net debt / op. profit	-0.52	-0.33	0.9	1.88
Cost breakup (₹)
Material costs	-43.23	-48.04	-57.31	-59.79
Employee costs	-14.33	-14.84	-16.18	-19.51
Other costs	-17.74	-20.16	-17.01	-14.85